Cover Image

Modeling the impact of the difference in cross-protection data between a human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and a human papillomavirus (HPV)-6/11/16/18 vaccine in Canada

<p>Background</p> <p>In Canada, two vaccines that have demonstrated high efficacy against infection with human papillomavirus (HPV) types −16 and −18 are available. The HPV-6/11/16/18 vaccine provides protection against genital warts (GW) while the HPV-16/18 vaccine may provide bet...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kohli Michele (Author), Lawrence Donna (Author), Haig Jennifer (Author), Anonychuk Andrea (Author), Demarteau Nadia (Author)
Format:	Book
Published:	BMC, 2012-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cost-effectiveness analysis of AS04-adjuvanted human papillomavirus 16/18 vaccine compared with human papillomavirus 6/11/16/18 vaccine in the Philippines, with the new 2-dose schedule
by: Maria Julieta Germar, et al.
Published: (2017)

Monitoring the safety of the adjuvanted human papillomavirus vaccine, HPV-16/18-AS04: Protocol for a cohort study using electronic health records in Yinzhou, China
by: Junting Yang, et al.
Published: (2024)

Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer screening in Hungary
by: Vokó Zoltán, et al.
Published: (2012)

The prevalence of human papillomavirus genotypes (HPV-6, HPV-11, HPV-16, and HPV-18) in the unilateral and bilateral nasal polyps
by: Amani M Abd Elwahab, et al.
Published: (2017)

P16 Protein and Human Papillomavirus (HPV16, 18) Expressions in Oral Lichen Planus and Squamous Cell Carcinoma
by: Suhaib R Muhsin, et al.
Published: (2015)

Safety of the AS04-adjuvanted human papillomavirus (HPV)-16/18 vaccine in adolescents aged 12-15 years: end-of-study results from a community-randomized study up to 6.5 years
by: Dan Bi, et al.
Published: (2020)

Detection of High-Risk Human Papillomavirus in Cervix Sample in an 11.3-year Follow-Up after Vaccination against HPV 16/18
by: Cirbia Silva Campos Teixeira, et al.
Published: (2017)

Screening and detection of human papillomavirus (HPV) high-risk strains HPV16 and HPV18 in saliva samples from subjects under 18 years old in Nevada: a pilot study
by: Flake Colton, et al.
Published: (2012)

Human papillomavirus and HPV vaccines: a review
by: FT Cutts, et al.

Efficacy of the AS04-adjuvanted HPV-16/18 vaccine in young Chinese women with oncogenic HPV infection at baseline: post-hoc analysis of a randomized controlled trial
by: Shangying Hu, et al.
Published: (2021)

Susceptibility of Male who Have Sex with Male to High-Risk Type Human Papillomavirus (HPV) 16 and 18 with Condyloma Acuminata
by: Prasetyadi Mawardi, et al.
Published: (2022)

Human papillomavirus type 16 (HPV-16) E5 protein and HLA class I
by: MR Haghshenas, et al.
Published: (2005)

Human papillomavirus type 16 (HPV-16) E5 protein and HLA class I
by: MR Haghshenas, et al.
Published: (2005)

The association between maternal human papillomavirus (HPV) experiences and HPV vaccination of their children
by: Erika Biederman, et al.
Published: (2021)

Correlates of human papillomavirus (HPV) vaccination initiation and completion among 18-26 year olds in the United States
by: Eric Adjei Boakye, et al.
Published: (2018)

Sexual behavior and infection with cervical human papillomavirus types 16 and 18
by: Itarat Y, et al.
Published: (2019)

The knowledge and attitudes of students about human papillomavirus and HPV vaccine
by: Antić Ljiljana, et al.
Published: (2018)

Safety and immunogenicity of a bivalent HPV16/18 vaccine in Chinese females
by: Li-Wei Shi, et al.
Published: (2023)

Safety profile of the 9-valent human papillomavirus vaccine: assessment in prior quadrivalent HPV vaccine recipients and in men 16 to 26 years of age
by: E. D. Moreira, et al.
Published: (2018)

Medical students' knowledge about human papillomavirus (HPV), HPV vaccine and head and neck cancer
by: Norangelys Solis-Torres, et al.
Published: (2024)

Knowledge and awareness of Human Papillomavirus (HPV) and HPV vaccines among Caribbean youth: the case of the Bahamas
by: Clemon George, et al.
Published: (2020)

RESULTS OF THE IMPLEMENTATION OF THE HPV (HUMAN PAPILLOMAVIRUS) VACCINATION PROGRAM IN THE MOSCOW REGION
by: article editorial
Published: (2017)

Pharmacists' Attitudes and Perceived Barriers to Human Papillomavirus (HPV) Vaccination Services
by: Tessa J. Hastings, et al.
Published: (2017)

Prevention of cervical, vaginal, and vulval cancers: role of the quadrivalent human papillomavirus (6, 11, 16, 18) recombinant vaccine
by: Maria Lina Diaz
Published: (2009)

A novel vaccine for cervical cancer: quadrivalent human papillomavirus (types 6, 11, 16 and 18) recombinant vaccine (Gardasil®)
by: Vandana A Govan
Published: (2008)

GARDASIL. QUADRIVALENT RECOMBINANT VACCINE AGAINST HPV (6, 11, 16, 18 TYPES)
by: article editorial
Published: (2007)

GARDASIL. QUADRIVALENT RECOMBINANT VACCINE AGAINST HPV (6, 11, 16, 18 TYPES)
by: article editorial
Published: (2007)

Prospective, multi-center post-marketing surveillance cohort study to monitor the safety of the human papillomavirus-16/18 AS04-adjuvanted vaccine in Chinese girls and women aged 9 to 45 years, 2018-2020
by: Qianhui Wu, et al.
Published: (2023)

A ten-year study of immunogenicity and safety of the AS04-HPV-16/18 vaccine in adolescent girls aged 10-14 years
by: Tino F. Schwarz, et al.
Published: (2019)

Vacinas contra rotavírus e papilomavírus humano (HPV) Vaccines against rotavirus and human papillomavirus (HPV)
by: Alexandre C. Linhares, et al.
Published: (2006)

Is It Time to Genotype Beyond HPV16 and HPV18 for Cervical Cancer Screening?
by: Brandon Wen Bing Chua, et al.
Published: (2022)

Human papillomavirus (HPV) vaccines in adults: Learnings from long-term follow-up of quadrivalent HPV vaccine clinical trials
by: Stephen E. Goldstone
Published: (2023)

Post-marketing surveillance study of the safety of the HPV-16/18 vaccine in Korea (2017-2021)
by: Byung-Wook Eun, et al.
Published: (2023)

Kosovo women's knowledge and awareness of human papillomavirus (HPV) infection, HPV vaccination, and its relation to cervical cancer
by: Pranvera Zejnullahu Raçi, et al.
Published: (2021)

The impact of vaccination on gender equity: conceptual framework and human papillomavirus (HPV) vaccine case study
by: Allison Portnoy, et al.
Published: (2020)

Concordance of Human Papillomavirus Type 16 and 18 in Cervical and Oral Specimen of Cervical Cancer Patients
by: Willy Akbar, et al.
Published: (2019)

Safety of human papillomavirus 6, 11, 16 and 18 (recombinant): systematic review and meta-analysis
by: Pedro Luiz Spinelli Coelho, et al.
Published: (2015)

Rapid detection of high-risk HPV16 and HPV18 based on microchip electrophoresis
by: Zhaoxuan Fan, et al.
Published: (2020)

Have you ever heard of Human Papillomavirus (HPV) vaccine? The awareness of HPV vaccine for college students in China based on meta-analysis
by: Gang Yin, et al.
Published: (2021)

Human Papillomavirus (HPV): unawareness of the causal role of HPV infection in cervical cancer, HPV vaccine availability, and HPV vaccine uptake among female schoolteachers in a Middle Eastern country
by: Juman Rezqalla, et al.
Published: (2021)